• Developmental SSRI Exposure and Motivation Deficits

  2026-08-17

  A 2026 Columbia dissertation shows that developmental SSRI exposure produces a selective motivational deficit in adolescent and adult mice, while reward liking and Pavlovian learning remain comparatively intact. Its most distinctive finding is that mu opioid receptor antagonism or nucleus accumbens knockdown can attenuate the deficit, identifying opioid-reward circuitry as a potential mechanistic target distinct from repeated SSRI treatment.

• SMYD2, miR-125b, and Drug Resistance in ccRCC

  2026-08-17

  The 2019 Theranostics study identifies SMYD2 as a prognostic and functional driver of clear cell renal cell carcinoma, linking its activity to the miR-125b/DKK3 pathway and P-glycoprotein-mediated multidrug resistance. Its combination of patient-prognostic analysis, epigenetic profiling, mechanistic cell assays, drug-response testing, and xenograft validation provides a framework for studying resistance-modifying strategies in renal cancer.

• Cirsium setidens Protects Against Doxorubicin Cardiotoxicity

  2026-08-16

  A 2024 Phytomedicine study shows that a hydroethanolic extract of Cirsium setidens protects cardiomyocytes from Doxorubicin-associated mitochondrial injury through an AMPK–PGC-1α–NRF1–SOD axis. The extract reduced cardiac toxicity in cellular, mouse, and human iPSC-derived cardiomyocyte models while preserving Doxorubicin-induced death in a breast cancer model.

• Plk1 Control of p31comet in Mitotic Checkpoint Exit

  2026-08-15

  The reference study identifies Polo-like kinase 1 as a negative regulator of p31comet-driven mitotic checkpoint complex disassembly. By combining HeLa cell extracts, purified proteins, kinase inhibition, and an S102A mutant, the authors show how Plk1 phosphorylation restrains checkpoint termination during mitotic arrest.

• Sodium Ascorbate: Designing Redox-Immune Assays

  2026-08-14

  Sodium Ascorbate can do more than generate oxidative stress in cancer models. This article presents an assay-design framework that connects redox-mediated tumor-cell injury with biomarker-rich immunotherapy research while defining the limits of that cross-domain interpretation.

• Demethyleneberberine: Mitochondrial Assay Strategy

  2026-08-14

  Demethyleneberberine (DMB) is more than a broad anti-inflammatory natural product: its strongest experimental value lies in resolving how TLR4, mitochondria, NLRP3, and IL-1β maturation interact. This article translates that mechanism into practical assay design, controls, dosing logic, and cross-disease interpretation.

• Mc-Val-Cit-PABC-PNP: ADC Workflow Guide

  2026-08-13

  Mc-Val-Cit-PABC-PNP is a cathepsin-cleavable peptide linker for antibody-drug conjugate workflows that require lysosomal payload release. This guide covers solvent selection, material calculations, conjugation planning, and QC while defining its limits: the free linker is insoluble in water and ethanol, solutions should be used promptly, and the product is for research use only.

• Nuclear cGAS Restricts LINE-1 Retrotransposition

  2026-08-13

  The reference study identifies a nuclear genome-protection function for cGAS: it suppresses LINE-1 retrotransposition by promoting TRIM41-dependent ubiquitination and degradation of ORF2p. Its DNA-damage-responsive CHK2–cGAS–TRIM41–ORF2p axis connects innate immune signaling, transposon control, aging, and tumorigenesis while also defining testable limitations for pharmacological DNA damage response studies.

• 5-Azacytidine: From Demethylation to Dormancy

  2026-08-12

  5-Azacytidine is more than a conventional DNMT inhibitor: its biological impact can range from cytotoxicity in proliferating leukemia cells to durable dormancy reprogramming in disseminated cancer cells. This thought-leadership perspective connects molecular mechanism, experimental design, product strategy, and translational decision-making.

• Recombinant Annexin V for Apoptosis Detection

  2026-08-12

  Brumatti, Sheridan, and Martin established a practical workflow for producing soluble, polyhistidine-tagged recombinant annexin V in Escherichia coli, followed by FITC labeling and apoptotic-cell analysis. The study’s main contribution is methodological: it makes phosphatidylserine exposure assays more accessible for flow cytometry and fluorescence microscopy while clarifying their biological interpretation and limitations.

• Tiamulin (Thiamutilin) Research Workflows

  2026-08-11

  Build more reproducible antibacterial and anti-inflammatory studies with Tiamulin, from strain-level susceptibility testing to poultry, swine, and cell-based models. This guide connects pleuromutilin mechanism, PK/PD planning, and practical troubleshooting without confusing exploratory findings with clinical treatment guidance.

• From TaCKX11-D to Phosphorylation-Aware Translation

  2026-08-11

  The TaCKX11-D wheat study shows how kinase-dependent phosphorylation can connect cytokinin homeostasis with grain development. This thought-leadership article explains how Phosbind Acrylamide can help translational researchers test that connection through antibody-independent, phosphorylation-sensitive SDS-PAGE workflows.

• Bacitracin B1670: Protocol and QC Guide

  2026-08-10

  Bacitracin (SKU B1670) is a peptide antibiotic for controlled antibacterial research involving bacterial cell wall and peptidoglycan synthesis. It is intended for scientific research workflows only and should not be used for diagnostic, clinical, or medical applications.

• Okadaic acid: PP1/PP2A Workflow Guide

  2026-08-09

  Okadaic acid (A4540) supports controlled inhibition of PP2A and PP1 when researchers need to examine phosphorylation-dependent signaling, apoptosis, or phosphatase activity. It should be titrated within the selected model and paired with vehicle, viability, and orthogonal pathway controls rather than treated as a universal apoptosis inducer or broad-spectrum phosphatase blocker.

• From ROS to Cell-Cycle Evidence in CRC

  2026-08-08

  A translational framework for using PI-based DNA-content profiling to connect CGF-driven metabolic stress with cell-cycle arrest and apoptosis in colorectal cancer research.

7996 records 4/534 page Previous Next 12345 下5页 Last page